浏览全部资源
扫码关注微信
- Journal Information
- Archive
- Submission
- For Reviewers
- Statement and Policies
Effects of GW501516 on the injury of pulmonary artery endothelial cells induced by hypoxia and its mechanism
- ZHONGGUO YAOFANG Vol. 35, Issue 2, Pages: 179-185(2024)
- 作者机构：
武汉市第一医院心血管内科，武汉 430022
- 作者简介：
- 基金信息：
DOI：10.6039/j.issn.1001-0408.2024.02.10
CLC： R965Published：30 January 2024，
Received：06 June 2023，
Revised：20 November 2023，
扫 描 看 全 文
陈昌贵,易春峰,余志华等.GW501516对低氧致肺动脉内皮细胞损伤的影响及机制 Δ[J].中国药房,2024,35(02):179-185.
CHEN Changgui,YI Chunfeng,YU Zhihua,et al.Effects of GW501516 on the injury of pulmonary artery endothelial cells induced by hypoxia and its mechanism[J].ZHONGGUO YAOFANG,2024,35(02):179-185.
陈昌贵,易春峰,余志华等.GW501516对低氧致肺动脉内皮细胞损伤的影响及机制 Δ[J].中国药房,2024,35(02):179-185. DOI： 10.6039/j.issn.1001-0408.2024.02.10.
CHEN Changgui,YI Chunfeng,YU Zhihua,et al.Effects of GW501516 on the injury of pulmonary artery endothelial cells induced by hypoxia and its mechanism[J].ZHONGGUO YAOFANG,2024,35(02):179-185. DOI： 10.6039/j.issn.1001-0408.2024.02.10.
摘要
目的
2
探讨过氧化物酶体增殖物激活受体δ（PPARδ）激动剂GW501516对低氧诱导的肺动脉内皮细胞（PAECs）损伤的影响及机制。
方法
2
通过检测PAECs的相对存活率，观察GW501516的细胞毒性作用；采用Western blot法检测PPARδ蛋白的表达水平。建立低氧条件下PAECs损伤的细胞模型，以抗氧化剂
N
-乙酰半胱氨酸（NAC）为阳性对照，通过检测细胞凋亡率、细胞活力、乳酸脱氢酶（LDH）活性、活性氧（ROS）水平，考察GW501516对细胞损伤及ROS产生的影响。以核因子E2相关因子2（Nrf2）激活剂富马酸二甲酯（DMF）为阳性对照，在低氧条件下通过GW501516和（或）Nrf2抑制剂ML385孵育PAECs，以细胞损伤（细胞凋亡、细胞活力、LDH活性）及超氧化物歧化酶（SOD）、谷胱甘肽过氧化物酶（GPx）、过氧化氢酶（CAT）、丙二醛（MDA）、ROS水平及Nrf2、血红素加氧酶1（HO-1）、裂解型胱天蛋白酶3（C-caspase-3）蛋白的表达水平，探讨GW501516对低氧致PAECs损伤的作用机制。
结果
2
低氧刺激能够抑制PAECs内PPARδ蛋白的表达（
P
＜0.05），而GW501516可在低氧条件下促进PPARδ蛋白的表达且无明显的细胞毒性作用。GW501516可抑制PAECs凋亡，提高细胞活力，降低LDH活性及ROS水平。GW501516可通过激活Nrf2通路，上调PAECs内HO-1蛋白表达水平及SOD、GPx、CAT水平，降低MDA、ROS水平（
P
＜0.05），而Nrf2抑制剂ML385能够逆转GW501516的上述作用（
P
＜0.05）。GW501516下调C-caspase-3蛋白表达，抑制低氧诱导的PAECs损伤的作用与Nrf2激活剂DMF相似（
P
＜0.05），而Nrf2抑制剂ML385能够逆转GW501516抑制PAECs损伤的作用（
P
＜0.05）。
结论
2
GW501516可通过抑制氧化应激来减轻低氧诱导的PAECs损伤，其机制与激活Nrf2有关。
Abstract
OBJECTIVE
2
To investigate the effects of the peroxisome proliferator-activated receptors δ （PPARδ） agonist GW501516 on the injury of pulmonary artery endothelial cells （PAECs） induced by hypoxia and its mechanism.
METHODS
2
The cytotoxic effects of GW501516 were observed by detecting the relative survival rate of PAECs； the protein expression of PPARδ was determined by Western blot assay. The cellular model of PAECs injury was established under hypoxic conditions； using antioxidant
N
-acetylcysteine （NAC） as positive control， the effects of GW501516 on cell injury and reactive oxygen species （ROS） production were investigated by detecting cell apoptotic rate， cell viability， lactate dehydrogenase （LDH） activity and ROS levels. Using nuclear factor erythroid 2-related factor 2（Nrf2） activator dimethyl fumarate （DMF） as positive control， PAECs were incubated with GW501516 and/or Nrf2 inhibitor ML385 under hypoxic conditions； the mechanism of GW501516 on PAECs injury induced by hypoxia was investigated by detecting cell injury （cell apoptosis， cell viability， LDH activity）， the levels of superoxide dismutase （SOD）， glutathione peroxidase （GPx）， catalase （CAT）， malondialdehyde （MDA） and ROS， the expressions of Nrf2， heme oxygenase-1 （HO-1） and cleaved-caspase-3 （C-caspase-3） protein.
RESULTS
2
The results demonstrated that hypoxia inhibited the protein expression of PPARδ （
P
＜0.05）， while GW501516 promoted the protein expression of PPARδ in hypoxia-exposed PAECs without obvious cytotoxic effects. GW501516 inhibited the apoptosis of PAECs， improved cell viability， and reduced LDH activity and ROS levels. GW501516 could up-regulate the protein expression of HO-1 in PAECs and the levels of SOD， GPx and CAT， while down-regulated the levels of MDA and ROS by activating the Nrf2 pathway （
P
＜0.05）； but Nrf2 inhibitor ML385 could reverse the above effects of GW501516 （
P
＜0.05）. GW501516 exerted similar effects to Nrf2 activator DMF in down-regulating the expression of C-caspase-3 and inhibiting the injury of PAECs under conditions of hypoxia （
P
＜0.05）. Moreover， Nrf2 inhibitor ML385 reversed the inhibition effects of GW501516 on PAECs injury （
P
＜0.05）.
CONCLUSIONS
2
GW501516 can relieve the hypoxia-induced injury of PAECs via the inhibition of oxidative stress， the mechanism of which may be associated with activating Nrf2.
关键词
GW501516低氧肺动脉内皮细胞氧化应激损伤核因子E2相关因子2
Keywords
hypoxiapulmonary artery endothelial cellsoxidative stressinjurynuclear factor erythroid 2-related factor 2
references
EVANS C E，COBER N D，DAI Z Y，et al. Endothelial cells in the pathogenesis of pulmonary arterial hypertension[J]. Eur Respir J，2021，58（3）：2003957.
XIAO L，WANG N P. PPAR-δ：a key nuclear receptor in vascular function and remodeling[J]. J Mol Cell Cardiol，2022，169：1-9.
BOJIC L A，BURKE A C，CHHOKER S S，et al. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation，insulin resistance，and atherosclerosis in low-density lipoprotein receptor knockout mice[J]. Arterioscler Thromb Vasc Biol，2014，34（1）：52-60.
TIAN D Y，MENG J Q，LI L，et al. Hydrogen sulfide ameliorates senescence in vascular endothelial cells through ameliorating inflammation and activating PPARδ/SGLT2/STAT3 signaling pathway[J]. Acta Biochim Biophys Sin，2023，55（9）：1358-1369.
KANG E S，HWANG J S，LEE W J，et al. Ligand-activated PPARδ inhibits angiotensin Ⅱ-stimulated hypertrophy of vascular smooth muscle cells by targeting ROS[J]. PLoS One，2019，14（1）：e0210482.
陈昌贵，易春峰，王栋，等. PPARδ的激活通过抑制糖酵解减轻PDGF-BB诱导的肺动脉平滑肌细胞表型转化[J]. 中国病理生理杂志，2023，39（6）：988-995.
CHEN C G，YI C F，WANG D，et al. Activation of PPARδ suppresses phenotypic switching of PDGF-BB-induced pulmonary artery smooth muscle cells via inhibition of glycolysis[J]. Chin J Pathophysiol，2023，39（6）：988-995.
YAMADA T，EGASHIRA N，BANDO A，et al. Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury[J]. Free Radic Biol Med，2012，52（8）：1285-1293.
PASCALE C L，MARTINEZ A N，CARR C，et al. Treatment with dimethyl fumarate reduces the formation and rupture of intracranial aneurysms：role of Nrf2 activation[J]. J Cereb Blood Flow Metab，2020，40（5）：1077-1089.
JIN D H，LIN L H，XIE Y X，et al. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease[J]. FASEB J，2022，36（1）：e22098.
JIANG Y，LIU H Y，YU H，et al. Circular RNA Calm4 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis via the circ-Calm4/miR-124-3p/PDCD6 axis[J]. Arterioscler Thromb Vasc Biol，2021，41（5）：1675-1693.
WANG R，PAN J J，HAN J Z，et al. Melatonin attenuates dasatinib-aggravated hypoxic pulmonary hypertension via inhibiting pulmonary vascular remodeling[J]. Front Cardiovasc Med，2022，9：790921.
HAN J K，LEE H S，YANG H M，et al. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the pho-sphatidylinositol 3-kinase/Akt pathway[J]. Circulation，2008，118（10）：1021-1033.
AIMAIER S，YANG T，FANG L，et al. Protective effects of the Terminalia bellirica tannin-induced Nrf2/HO-1 signaling pathway in rats with high-altitude pulmonary hypertension[J]. BMC Complement Med Ther，2023，23（1）：150.
孙鹤宁，鲁美丽，田小雪，等. Calpain-1通过诱导内质网应激加速肺动脉高压的内皮细胞凋亡[J]. 中国药理学通报，2023，39（4）：723-730.
SUN H N，LU M L，TIAN X X，et al. Calpain-1 accele-rates endothelial cell apoptosis in pulmonary hypertension by inducing endoplasmic reticulum stress[J]. Chin Pharmacol Bull，2023，39（4）：723-730.
LIU F，FANG S H，LIU X X，et al. Omentin-1 protects against high glucose-induced endothelial dysfunction via the AMPK/PPARδ signaling pathway[J]. Biochem Pharmacol，2020，174：113830.
TIAN Q Q，LEUNG F P，CHEN F M，et al. Butyrate protects endothelial function through PPARδ/miR-181b signaling[J]. Pharmacol Res，2021，169：105681.
CHEN Y C，YUAN T Y，ZHANG H F，et al. Activation of Nrf2 attenuates pulmonary vascular remodeling via inhibiting endothelial-to-mesenchymal transition：an insight from a plant polyphenol[J]. Int J Biol Sci，2017，13（8）：1067-1081.
ARCHER S L，MARSBOOM G，KIM G H，et al. Epige-netic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension：a basis for excessive cell proliferation and a new therapeutic target[J]. Circulation，2010，121（24）：2661-2671.
葛亮，向悦华，谭旎. Nrf2激活剂缓解低氧性肺动脉高压大鼠肺血管重构[J]. 基础医学与临床，2021，41（10）：1446-1450.
GE L，XIANG Y H，TAN N. Nrf2 activator relieves pulmonary vascular remodeling in rats with hypoxic pulmonary arterial hypertension[J]. Basic Clin Med，2021，41（10）：1446-1450.
JIMENEZ R，TORAL M，GÓMEZ-GUZMÁN M，et al. The role of Nrf2 signaling in PPARβ/δ-mediated vascular protection against hyperglycemia-induced oxidative stress[J]. Oxid Med Cell Longev，2018，2018：5852706.
D'USCIO L V，HE T R，SANTHANAM A V，et al. Mechanisms of vascular dysfunction in mice with endo-thelium-specific deletion of the PPAR-δ gene[J]. Am J Physiol Heart Circ Physiol，2014，306（7）：H1001-H1010.
0
Views
1
下载量
0
CSCD
- L-PDFDownload
- WORDDownload
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
- Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号
公网安备50010302001817 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.